Our take on the latest news and views on data.
Relevant company news, articles, podcasts, and blog posts.
Recent Posts
Using Data to Optimize Clinical Trial Recruitment
The Importance of a High-Performing Clinical Trial Partnership Pharmaceutical companies are heavily dependent on clinical trials...
Uncovering New Catalyst Events in the Pharmaceutical and Biotech Markets
The Challenges with Predicting Catalyst Events “Chasing headlines” for catalyst events in the biotech and pharmaceutical markets...
New Developments in Alzheimer’s Treatment
OZMOSI’s predictions for where Alzheimer's treatment is headed. The Ravaging Effects of Alzheimer’s The devastation of living...
Industry Trends
Uncovering New Catalyst Events in the Pharmaceutical and Biotech Markets
The Challenges with Predicting Catalyst Events “Chasing headlines” for catalyst events in the biotech and pharmaceutical markets...
Finding the Needle in a Haystack with NLP
The problem with Big Data is that it is so Big! This issue is especially true in the world of healthcare and drug development. ...
Using NLP Data to Classify Patient Segments in Clinical Trial Data
One of the most common and powerful approaches in NLP provides the content experts an opportunity to label each data segment for...
Clinical Trial Trends
Using Data to Optimize Clinical Trial Recruitment
The Importance of a High-Performing Clinical Trial Partnership Pharmaceutical companies are heavily dependent on clinical trials...
The Clinical Trial Powershift
Pharmaceutical companies are being pushed aside when it comes to who is driving clinical outcomes. Despite the growing number of...
China Reshaping the Clinical Trial Pipeline
Finally, the data is in here at OZMOSI, and we can start tracking and reporting on the clinical development expected to come out...
Disease Area Trends
Covid-19 Clinical Trials and Where to Get Treated Update
Here is a quick update on the ever-evolving world of COVID-19 trials. Since our initial posting on this topic three weeks ago,...
Covid-19 Clinical Trials and Where to Get Treated
We all know the basics for fighting the COVID-19 virus, like washing our hands and staying socially distant from one another,...
ELI LILLY in the Diabetes Market
For years, Eli Lilly’s main contributions to the Diabetes market were their insulins: fast-acting analog Humalog® and human...
Novo Nordisk Diabetes Pipeline Analysis
Novo Nordisk remains a top player in the Diabetes market with blockbuster insulins NovoLog® and Levemir® which brought in...
Merck Diabetes Pipeline Analysis
Merck’s two blockbuster diabetes products, Janumet® and Januvia®, are DPP-4 inhibitors that generated nearly $3.3 billion in...
What do the big players have in store for the Diabetes market in the next 12 months?
Diabetes is one of the most prevalent diseases in the U.S., afflicting over 29 million people across Type 1 and Type 2 patients,...
Recent Tweets
💊 SPDR Pharma $XPH Movers Today 💉
Top 3 XPH Gainers:
$CARA (Cara Ther.) 5.42% 📈
$RVNC (Revance Ther.) 5.67% 📈
$ARVN (Arvinas) 5.98% 📈
Top 3 XPH Laggards:
$FULC (Fulcrum Ther.) -1.6% 🔻
$CORT (Corcept Ther.) -0.6% 🔻
$SUPN (Supernus Pharma) -0.1% 🔻
🧬 SPDR Biotech $XBI Movers Today 🩸
Top 3 XBI Gainers:
$AVXL (Anavex Life Sciences) 8.16% 📈
$FGEN (FibroGen) 9.31% 📈
$GOSS (Gossamer Bio) 10.92% 📈
Top 3 XBI Laggards:
$BTAI (BioXcel Ther.) -7.9% 🔻
$RCUS (Arcus Bio) -3.2% 🔻
$MRNA (Moderna) -2.7% 🔻
Get Started with OZMOSI
We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.
600 Warren Ave,
Spring Lake, NJ 07762